1. Keay L, Gower EW, Cassard SD, et al. Postcataract surgery endophthalmitis in the United States: analysis of the complete 2003 to 2004 Medicare database of cataract surgeries. Ophthalmology. 2012;119:914–922.
2. Lalitha P, Rajagopalan J, Prakash K, et al. Postcataractendophthalmitis in South India incidence and outcome. Ophthalmology. 2005;112:1884–1889.
3. Jambulingam M, Parameswaran SK, Lysa S, et al. A study on the incidence, microbiological analysis and investigations on the source of infection of postoperative infectious endophthalmitis in a tertiary care ophthalmic hos- pital: an 8-year study. Indian J Ophthalmol. 2010;58:297–302.
4. Wong TY, Chee SP. The epidemiology of acute endophthalmitis after cat- aract surgery in an Asian population. Ophthalmology. 2004;111:699–705.
5. Mollan SP, Gao A, Lockwood A, et al. Postcataractendophthalmitis: inci- dence and microbial isolates in a United Kingdom region from 1996 through 2004. J Cataract Refract Surg. 2007;33:265–268.
6. Lundstrom M, Wejde G, Stenevi U, et al. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology. 2007;114: 866–870.
7. Barry P, Cordoves L, Gardner S. ESCRS Guidelines for Prevention and Treatment of Endophthalmitis Following Cataract Surgery: Data, Dilema and Conclusions. Dublin, Ireland, The European Society for Cataract & Refractive Surgeons, Temple House, Temple Road, Blackrock, Co, 2013. Available at: http://www. escrs.org/endophthalmitis/guidelines/ENGLISH. pdf. Accessed December 6, 2015.
8. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002;109:13–24.
9. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age- related macular degeneration. N Engl J Med. 2006;355:1419–1431.
10. Avery RL, Pieramici DJ, Rabena MD, et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006;113:363–372.
11. Inoue M, Kobayakawa S, Sotozono C, et al. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor. Ophthalmologica. 2011;226:145–150.
12. Haritoglou C, Kook D, Neubauer A, et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina. 2006;26:999–1005.
13. Chun DW, Heier JS, Topping TM, et al. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clin- ically significant diabetic macular edema. Ophthalmology. 2006;113: 1706–1712.
14. Rabena MD, Pieramici DJ, Castellarin AA, et al. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina. 2007;27:419–425.
15. Hoevenaars NE, Gans D, Missotten T, et al. Suspected bacterial endophthalmitis following intravitreal anti-VEGF injection: case series and litera- ture review. Ophthalmologica. 2012;228:143–147.
16. Fintak DR, Shah GK, Blinder KJ, et al. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina. 2008;28: 1395–1399.
17. Durand ML. Endophthalmitis. ClinMicrobiol Infect 2013;19:227–234.
18. Callegan MC, Engelbert M, Parke DW, et al. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev. 2002;15:111–124.
19. Willcox MD. Characterization of the normal microbiota of the ocular surface. Exp Eye Res. 2013;117:99–105.
20. Speaker MG, Milch FA, Shah MK, et al. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 1991;98:639–649.
21. Ta CN, Egbert PR, Singh K, et al. Prospective randomized comparison of 3- day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmology. 2002;109:2036–2040.
22. Chang DF, Braga-Mele R, Mamalis N, et al. Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey. J Cataract Refract Surg. 2007;33:1801–1805.
23. Gawronska M, Kaluzny J, Mikucka A, et al. Bacterial flora of conjunctival sac in patients with cataract. Methods of disinfection and evaluation of their efficiency. Klin Oczna. 2005;107:408–413.
24. Girardeau-Hubert S, Teluob S, Pageon H, et al. The reconstructed skin model as a new tool for investigating in vitro dermal fillers: increased fibroblast activity by hyaluronic acid. Eur J Dermatol. 2015; 25:312–322.
25. Bylka W, Znajdek-Awiz_e’n P, Studzinska-Sroka E, et al. Centellaasiatica in dermatology: an overview. Phytother Res. 2014;28:1117–1124.
26. Carron A, Samudio M, Laspina F, et al. Efficacy of topical 0.3% ciprofloxacin application in reducing the conjunctival biota of patients undergoing cataract extraction. Arch Soc Esp Oftalmol. 2013;88:345–351.
27. Li B, Nentwich MM, Hoffmann LE, et al. Comparison of the efficacy of
28. povidone-iodine 1.0%, 5.0%, and 10.0% irrigation combined with topical levofloxacin 0.3% as preoperative prophylaxis in cataract surgery. J Cata- ract Refract Surg. 2013;39:994–1001.
29. Vasavada AR, Gajjar D, Raj SM, et al. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple- masked trial. Part 2: residual conjunctival flora. J Cataract Refract Surg. 2008;34:1383–1388.
30. Hofling-Lima A, Farah M, Montenegro L. Changes in conjunctival and lid flora after topical use of lomefloxacin and tobramycin in cataract and refrac- tive surgery. Arq Bras Oftalmol. 2002;65:21–29.
31. HuesoAbancens JR, Mengual VE, Schargel PK, et al. Modification of the conjuntivalflora with cleaning palpebral solutions. Arch Soc Esp Oftalmol. 2004;79:617–621.
32. Apt L, Isenberg S, Yoshimori R, et al. Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva. Arch Ophthalmol. 1984;102:728–729.
33. Halachmi-Eyal O, Lang Y, Keness Y, et al. Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac. J Cataract Refract Surg. 2009;35:2109–2114.
Репозиторий OAI—PMH
Репозиторий Российская Офтальмология Онлайн по протоколу OAI-PMH
Конференции
Офтальмологические конференции и симпозиумы
Видео
Видео докладов
| Литература | Полный текст |
A. Peral, J. Alonso, C. Garcia-Garcia, Cristina Nino-Rueda, Patricia Calvo
Роль гигиены век в предоперационной подготовке: количественный и качественный анализ бактериальной обсемененности век и конъюнктивы
Страница источника: 52-58
Каталог
Продукции
Организации
Офтальмологические клиники, производители и поставщики оборудования
Издания
Периодические издания
Партнеры
Проекта Российская Офтальмология Онлайн
